Tag Archives: NASDAQ:EXEL

Analysts Are Bullish on These Healthcare Stocks: Exelixis (EXEL), Hologic (HOLX)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Exelixis (EXEL – Research Report) and Hologic (HOLX – Research Report) with bullish sentiments. Exelixis (EXEL) In a report released today, Jason

Cowen & Co. Remains a Buy on Exelixis (EXEL)

In a report released yesterday, Yaron Werber from Cowen & Co. maintained a Buy rating on Exelixis (EXEL – Research Report), with a price target of $23.00. The company’s shares closed last Monday at $18.32. According to TipRanks.com, Werber is

Exelixis (EXEL) Gets a Buy Rating from Needham

Needham analyst Chad Messer maintained a Buy rating on Exelixis (EXEL – Research Report) today and set a price target of $30.00. The company’s shares closed last Monday at $17.86. According to TipRanks.com, Messer is a 4-star analyst with an

Exelixis (EXEL) Gets a Buy Rating from Cowen & Co.

Cowen & Co. analyst Yaron Werber maintained a Buy rating on Exelixis (EXEL – Research Report) today and set a price target of $23.00. The company’s shares closed last Monday at $18.12. According to TipRanks.com, Werber is a 5-star analyst

The EVP, Scientific Strategy & CSO of Exelixis (NASDAQ: EXEL) is Buying Shares

Yesterday, the EVP, Scientific Strategy & CSO of Exelixis (EXEL – Research Report), Peter Lamb, bought shares of EXEL for $897.9K. Following this transaction Peter Lamb’s holding in the company was increased by 1767.22% to a total of $3.18 million.

Exelixis (EXEL) Receives a Buy from Oppenheimer

In a report released yesterday, Silvan Tuerkcan from Oppenheimer maintained a Buy rating on Exelixis (EXEL – Research Report), with a price target of $28. The company’s shares closed yesterday at $20.55. Tuerkcan commented: “EXEL has come under pressure following